Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems.

As COVID-19 vaccines roll out, doctors say it's long past time to address the exclusion of pregnant women from research on drugs and vaccines. They say better study design is the answer.

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Two studies find that tailoring brain stimulation to a particular patient helps in treating depression and obsessive-compulsive behaviors.

The evidence is strong that some people struggling with meth addiction benefit from the drug regime.

Antibody-based drugs that bind to the coronavirus to prevent it from invading cells can help patients with mild to moderate COVID-19. But the medicines can be tough to find in time.

With case and death counts still surging, the pressure is on to vaccinate as many people as possible. Here's what it will take to get more Americans their shots, fast.

While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.

Severe cases of COVID-19 can injure the brain in ways that affect memory, thinking and mood for months after the infection is gone, new research hints. It may even raise the risk of Alzheimer's.

Boston Children's Hospital saw a precipitous drop in cases during the spring shutdown, and the trend continues. Researchers are asking why — and what it would take to keep up the change post-pandemic.

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.

Fingertip devices that measure oxygen in the blood can sometimes give erroneous readings in people with dark skin, doctors report. The devices can say oxygen levels are normal when they're not.

The new tests produce results completely at home within 15 minutes. Experts say they could be a 'game-changer' in helping people find out quickly if they need to isolate.

As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.

An independent federal advisory committee to the CDC recommends the Pfizer-BioNTech vaccine for people over 16. But state health leaders say distribution and funding challenges remain.